India is an emporium of medicinal plants. Indian systems of medicine as well as folkloric systems are utilizing medicinal plant wealth from very ancient times for combating a wide array of human ailments. There exists a history of facing several pandemics including Small pox, Tuberculosis, Spanish Flu, Malaria etc. using traditional herbal medicines. National Medicinal Plant Board had suggested selected twenty medicinal plants including Amla, Aswagandha, Basil, Giloe, Cinnamon, Clove etc. as a prophylaxis or support therapy for curing COVID-19 related ailments. In addition, in silo, in vitro and pre-clinical evidences exhibiting the anti-COVID-19 activity of these medicinal plants revealed the scope for development of plant derived anti-COVID drugs.
COVID-19, Medicinal Plants, NMPB, traditional herbal medicines, curing COVID-19, Amla, Aswagandha, Basil, Giloe, Cinnamon, Clove
Balkrishna, A., Pokhrel, S., Singh, J., & Varshney, A. (2020). Withanone from Withania somnifera may inhibit novel coronavirus (COVID-19) entry by disrupting interactions between viral S-protein receptor binding domain and host ACE2 receptor. Research Square.
Balkrishna, A., Solleti, S. K., Verma, S., & Varshney, A. 2020. Application of humanized zebrafish model in the suppression of SARS-CoV-2 spike protein induced pathology by tri-herbal medicine coronil via cytokine modulation. Molecules, 25(21), 1-25.
Enmozhi, S. K., Raja, K., Sebastine, I., & Joseph, J. 2020. Andrographolide as a potential inhibitor of SARS-CoV-2 main protease: an in silico approach. Journal of Biomolecular Structure and Dynamics, 39(9), 3092-3098.
Gheware, A., Dholakia, D., Kannan, A., Panda, L., Rani, R., Pattnaik, B. R., Jain, V., Parekh, Y., Enayathullah, M. G., Bokara, K. K., Subramanian, V., Mukarji, M., Agrawal, A., & Prasher, B. (2021). Adhatoda vasica attenuates infammatory and hypoxic responses in preclinical mouse models: potential for repurposing in COVID-19-like conditions. Respiratory Research, 22 (1), 1-15.
Kar, P., Sharma, N. R., Singh, B., Sen, A., & Roy, A. (2020). Natural compounds from Clerodendrum spp. as possible therapeutic candidates against SARS-CoV-2: An in silico investigation. Journal of Biomolecular Structure and Dynamics.
Koulgi, S., Jani, V., Uppuladinne, V. N. M., Sonavane, U., & Joshi, R. (2021). Natural plant products as potential inhibitors of RNA dependent RNA polymerase of Severe Acute Respiratory Syndrome Coronavirus-2. Plos One, 16 (5).
Kumar, A. (2020). Molecular docking of natural compounds from tulsi (Ocimum sanctum) and neem (Azadirachta indica) against SARS-CoV-2 protein targets. Research Square.
NMPB (National Medicinal Plant Board). 2021. 20 Medicinal Plants of ’21 for COVID-19 care. Ministry of Ayush, Government of India, 49p.
Obeta, M. U. (2020). Anti-COVID-19 Properties of ginger (Zingiber officinale) assisted Enugu - Nigerian people during the pandemic. Journal of Bacteriology and Infectious Diseases, 4(3), 1-5.
Pandey, P., Singhal, D., Khan, F., & Arif, M. (2020). An In Silico screening on Piper nigrum, Syzygium aromaticum and Zingiber officinale roscoe derived compounds against SARS-CoV-2: A drug repurposing approach. Biointerface Research in Applied Chemistry, 11 (4), 11122 – 11134.
Rajagopal, K., Varakumar, P., Baliwada, A., & Byran, G. (2020). Activity of phytochemical constituents of Curcuma longa (turmeric) and Andrographis paniculata against coronavirus (COVID-19): an in silico approach. Future Journal of Pharmaceutical Sciences, 6, 1-12.
Sagar, V. & Kumar, A. H. S. (2020). Efficacy of natural compounds from Tinospora cordifolia against SARS-CoV-2 protease, surface glycoprotein and RNA polymerase. Journal of Virology, 1-10.
Sahu, P. K., Sarangi, S., Bhoi, B., & Gadtya, A. S. (2020). In Silico analysis of COVID-19 prevention using Cinnamomum verum extract by blocking ADP ribose phosphates protein of NSP3 enzyme. Indian Journal of Natural Sciences, 10 (60), 21483-21485.
Shafiq, M., Saif, R., Ali, L., Ahmad, T., & Sohail, A. (2021). Computer-aided drug designing of Ocimum basilicum compounds as therapeutic agents against RdRp of SARS-CoV2.
Srivastava, V., Yadav, A., & Sarkar, P. (2020). Molecular docking and ADMET study of bioactive compounds of Glycyrrhiza glabra against main protease of SARS-CoV2. Materials Today: Proceedings. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556787/
Tripathi, M. K., Singh, P., Sharma, S., Singh, T. P., Ethayathulla, A. S., & Kaur, P. (2020). Identification of bioactive molecule from Withania somnifera (Ashwagandha) as SARS-CoV-2 main protease inhibitor. Journal of Biomolecular Structure and Dynamics, 1–14.
Wu, C., Liu, Y., Yang, Y., Zhang, P., Zhong, W., & Wang, Y. (2020). Analysis of therapeutic targets of SARS-CoV-2 and discovery of potential drugs by computational methods. Acta Pharmaceutica Sinica B- Journal, 10 (5), 766-788.
Xin, Y. L., Janice, S. W. C., Terence, Y. C. T., Bee, P. T., Razak, M. R. M. A., Mohamad, S., & Mohamed, A. F. (2021). Andrographis paniculata (Burm. F.) Wall. Ex Nees, andrographolide, and andrographolide analogues as SARS-CoV-2 antivirals. A rapid review. Natural Product Communications, 16 (5), 1-15.
